196 related articles for article (PubMed ID: 15591246)
21. Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor.
Armstrong N; Jasti J; Beich-Frandsen M; Gouaux E
Cell; 2006 Oct; 127(1):85-97. PubMed ID: 17018279
[TBL] [Abstract][Full Text] [Related]
22. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of partial agonist action at the NR1 subunit of NMDA receptors.
Inanobe A; Furukawa H; Gouaux E
Neuron; 2005 Jul; 47(1):71-84. PubMed ID: 15996549
[TBL] [Abstract][Full Text] [Related]
24. Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant.
Johnson WD; Parandaman V; Onaivi ES; Taylor RE; Akinshola BE
Brain Res; 2008 Jul; 1222():18-30. PubMed ID: 18585685
[TBL] [Abstract][Full Text] [Related]
25. Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor.
Laube B; Schemm R; Betz H
Neuropharmacology; 2004 Dec; 47(7):994-1007. PubMed ID: 15555634
[TBL] [Abstract][Full Text] [Related]
26. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
Moretti L; Pentikäinen OT; Settimo L; Johnson MS
J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
[TBL] [Abstract][Full Text] [Related]
27. Structure of a glutamate-receptor ligand-binding core in complex with kainate.
Armstrong N; Sun Y; Chen GQ; Gouaux E
Nature; 1998 Oct; 395(6705):913-7. PubMed ID: 9804426
[TBL] [Abstract][Full Text] [Related]
28. Subtype selectivity and flexibility of ionotropic glutamate receptors upon antagonist ligand binding.
Pentikäinen U; Settimo L; Johnson MS; Pentikäinen OT
Org Biomol Chem; 2006 Mar; 4(6):1058-70. PubMed ID: 16525550
[TBL] [Abstract][Full Text] [Related]
29. Functional characterization and in silico docking of full and partial GluK2 kainate receptor agonists.
Fay AM; Corbeil CR; Brown P; Moitessier N; Bowie D
Mol Pharmacol; 2009 May; 75(5):1096-107. PubMed ID: 19225180
[TBL] [Abstract][Full Text] [Related]
30. Probing the ligand binding domain of the GluR2 receptor by proteolysis and deletion mutagenesis defines domain boundaries and yields a crystallizable construct.
Chen GQ; Sun Y; Jin R; Gouaux E
Protein Sci; 1998 Dec; 7(12):2623-30. PubMed ID: 9865957
[TBL] [Abstract][Full Text] [Related]
31. Stereochemistry of glutamate receptor agonist efficacy: engineering a dual-specificity AMPA/kainate receptor.
Madden DR; Cheng Q; Thiran S; Rajan S; Rigo F; Keinänen K; Reinelt S; Zimmermann H; Jayaraman V
Biochemistry; 2004 Dec; 43(50):15838-44. PubMed ID: 15595838
[TBL] [Abstract][Full Text] [Related]
32. Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites.
Kaae BH; Harpsøe K; Kastrup JS; Sanz AC; Pickering DS; Metzler B; Clausen RP; Gajhede M; Sauerberg P; Liljefors T; Madsen U
Chem Biol; 2007 Nov; 14(11):1294-303. PubMed ID: 18022568
[TBL] [Abstract][Full Text] [Related]
33. Kainate induces various domain closures in AMPA and kainate receptors.
Venskutonytė R; Frydenvang K; Hald H; Rabassa AC; Gajhede M; Ahring PK; Kastrup JS
Neurochem Int; 2012 Sep; 61(4):536-45. PubMed ID: 22425692
[TBL] [Abstract][Full Text] [Related]
34. A new phenylalanine derivative acts as an antagonist at the AMPA receptor GluA2 and introduces partial domain closure: synthesis, resolution, pharmacology, and crystal structure.
Szymańska E; Frydenvang K; Contreras-Sanz A; Pickering DS; Frola E; Serafimoska Z; Nielsen B; Kastrup JS; Johansen TN
J Med Chem; 2011 Oct; 54(20):7289-98. PubMed ID: 21923187
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanism of agonist recognition by the ligand-binding core of the ionotropic glutamate receptor 4.
Kasper C; Frydenvang K; Naur P; Gajhede M; Pickering DS; Kastrup JS
FEBS Lett; 2008 Dec; 582(29):4089-94. PubMed ID: 19022251
[TBL] [Abstract][Full Text] [Related]
36. Tuning activation of the AMPA-sensitive GluR2 ion channel by genetic adjustment of agonist-induced conformational changes.
Armstrong N; Mayer M; Gouaux E
Proc Natl Acad Sci U S A; 2003 May; 100(10):5736-41. PubMed ID: 12730367
[TBL] [Abstract][Full Text] [Related]
37. Correlating AMPA receptor activation and cleft closure across subunits: crystal structures of the GluR4 ligand-binding domain in complex with full and partial agonists.
Gill A; Birdsey-Benson A; Jones BL; Henderson LP; Madden DR
Biochemistry; 2008 Dec; 47(52):13831-41. PubMed ID: 19102704
[TBL] [Abstract][Full Text] [Related]
38. Tetrazolyl isoxazole amino acids as ionotropic glutamate receptor antagonists: synthesis, modelling and molecular pharmacology.
Frølund B; Greenwood JR; Holm MM; Egebjerg J; Madsen U; Nielsen B; Bräuner-Osborne H; Stensbøl TB; Krogsgaard-Larsen P
Bioorg Med Chem; 2005 Sep; 13(18):5391-8. PubMed ID: 16043357
[TBL] [Abstract][Full Text] [Related]
39. Selective agonist binding of (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) and 2S-(2alpha,3beta,4beta)-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid (kainate) receptors: a molecular modeling study.
Pentikäinen OT; Settimo L; Keinänen K; Johnson MS
Biochem Pharmacol; 2003 Dec; 66(12):2413-25. PubMed ID: 14637199
[TBL] [Abstract][Full Text] [Related]
40. Binding of 5'-GMP to the GluR2 AMPA receptor: insight from targeted molecular dynamics simulations.
Mendieta J; Gago F; Ramírez G
Biochemistry; 2005 Nov; 44(44):14470-6. PubMed ID: 16262247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
